NCT02379910View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

AM1030-CREAM or placebo

Trial Locations (2)

LS2 9LH

Covance CRU, Leeds

L7 8XP

CRLCRU Royal Liverpool University Hospital, Liverpool

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

AnaMar AB

INDUSTRY

NCT02379910 - A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter